| Literature DB >> 24071586 |
Stefano Majocchi1, Elena Aritonovska, Nicolas Mermod.
Abstract
In eukaryotic cells, transgene expression levels may be limited by an unfavourable chromatin structure at the integration site. Epigenetic regulators are DNA sequences which may protect transgenes from such position effect. We evaluated different epigenetic regulators for their ability to protect transgene expression at telomeres, which are commonly associated to low or inconsistent expression because of their repressive chromatin environment. Although to variable extents, matrix attachment regions (MARs), ubiquitous chromatin opening element (UCOE) and the chicken cHS4 insulator acted as barrier elements, protecting a telomeric-distal transgene from silencing. MARs also increased the probability of silent gene reactivation in time-course experiments. Additionally, all MARs improved the level of expression in non-silenced cells, unlike other elements. MARs were associated to histone marks usually linked to actively expressed genes, especially acetylation of histone H3 and H4, suggesting that they may prevent the spread of silencing chromatin by imposing acetylation marks on nearby nucleosomes. Alternatively, an UCOE was found to act by preventing deposition of repressive chromatin marks. We conclude that epigenetic DNA elements used to enhance and stabilize transgene expression all have specific epigenetic signature that might be at the basis of their mode of action.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24071586 PMCID: PMC3874193 DOI: 10.1093/nar/gkt880
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Figure 1.A dual reporter system for the study of epigenetic regulators at human telomeres. (A) Features of the reporter constructs used to assess the capacity of epigenetic regulatory elements in protecting gene expression at telomeres. Note the telomeric-proximal and telomeric-distal position of DsRed and eBFP2 relative to the MCS used to insert distinct regulatory or spacer control elements (DNA element). Quantitative PCR amplicons for both DsRed and eBFP2 are shown as bars underneath their respective location. (B) Expression profile of stably transfected HeLa cells carrying pSTE-TR-RB shows preferential silencing of the telomeric-proximal gene and moderate expression level of the telomeric-distal eBFP2 in a minority of cells.
Epigenetic regulators and control elements used in this study
| DNA elements | Element size (kb) | Plasmid full name | Short name |
|---|---|---|---|
| Empty vector | – | pSTE-TR-RB | 0 kb |
| 0.5 kb Utrophin control fragment | 0.5 | pSTE-TR-RB-0.5 kb | 0.5 kb CTRL |
| 1 kb Utrophin control fragment | 1 | pSTE-TR-RB-1 kb | 1 kb CTRL |
| 2 kb Utrophin control fragment | 2 | pSTE-TR-RB-2 kb | 2 kb CTRL |
| 3 kb Utrophin control fragment | 3 | pSTE-TR-RB-3 kb | 3 kb CTRL |
| 5.6 kb Utrophin control fragment | 5.6 | pSTE-TR-RB-5.6 kb | 5.6 kb CTRL |
| Human MAR 1-68 | 3.6 | pSTE-TR-RB-1-68 | 1-68 |
| Human MAR X-29 | 3.5 | pSTE-TR-RB-X-29 | X-29 |
| Murine MAR S4 | 5.4 | pSTE-TR-RB-S4 | S4 |
| Chicken Lysozyme MAR | 3 | pSTE-TR-RB-Lys | c-Lys |
| Human MAR 1-68 Core + flanking region | 1.4 | pSTE-TR-RB-C1-68 | Core 1-68 |
| 4X Core MAR X29 | 0.8 | pSTE-TR-RB-CX29 | Core X-29 |
| Chicken beta-globin HS4 Insulator | 1.2 | pSTE-TR-RB-HS4 | cHS4 |
| UCOE from the HNRPA2B1-CBX3 locus | 1 | pSTE-TR-RB-UCOE | UCOE |
| STAR Element 7 | 2.1 | pSTE-TR-RB-STAR7 | STAR 7 |
| STAR Element 40 | 1 | pSTE-TR-RB-STAR40 | STAR 40 |
Figure 2.Effect of epigenetic regulators on expressing cell occurrence in polyclonal populations. HeLa cells were stably transfected with pSTE-TR-RB vector bearing different epigenetic regulators or control sequences under antibiotic selection. After 2 weeks of further culture without selective pressure, cells were analysed by flow cytometry and the percentage of cells expressing either reporter gene was assessed in each cell population. Mean and standard deviation of three independent transfections are shown. Stars indicate statistically significant increase in the number of expressing cells compared with control populations where DsRed and eBFP2 are separated by neutral DNA sequences of equivalent size (Student’s t-test, *P < 0.05).
Figure 3.Analysis of monoclonal populations. Stably transfected and expressing cells were sorted into single cells and resulting monoclonal populations grown without selective pressure. For each epigenetic regulator, 12 expressing clones were analysed by cytofluorometry to determine the mean fluorescence of both eBFP2 and DsRed. Mean fluorescence of individual clones are represented as box plots of eBFP2 (A) and DsRed (B) and they were compared to that of cells generated with the spacer control of equivalent size (Student’s t-test: *P < 0.05; n = 12). Dots represent outlier clones which were excluded from further analysis. Mean fluorescence in untransfected HeLa cells is also shown as reference (Neg CTRL). Additionally, silenced cells (expressing neither eBFP2 nor DsRed) from stably transfected polyclonal populations were also sorted as monoclonal populations and further grown in the absence of selective pressure. Transgene expression in these silenced populations was followed by FACS over a period of 2 weeks (C), after which some clones displayed detectable eBFP2 fluorescence (indicated by an arrow). (D) Number of clones displaying eBFP2 expression activation events occurring within the silenced monoclonal populations, showing a significantly higher frequency for MAR elements taken together and for MAR 1-68 relative to the 3 kb spacer control (Fisher's exact test, *P < 0.05; n = 24).
Figure 4.Effect of epigenetic regulatory elements on histone modifications. The presence of histone modifications on eBFP2 and DsRed transgenes was assessed by ChIP with antibodies against acetylated H3 and H4, monomethylated H2BK5 and H3R2 and trimethylated H3K4, H3K9, H4K20 and H3K27. Immunoprecipitated DNA was analysed by quantitative PCR. For each DNA element, two clones were analysed and the mean and standard deviation of three independent experiments are represented as fold enrichment relative to the spacer control of similar size (Student’s t-test, *P < 0.05; **P < 0.01).
Histone modifications and other transcriptional activities associated with epigenetic regulators
| DNA element | Boundary activity | Transcriptional activation | Reactivation | Histone modifications | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Euchromatin | (Sub)telomeric | Heterochromatin | |||||||||
| AcH3 | AcH4 | H3K4me3 | H2BK5me1 | H3R2me1 | H3K9me3 | H4K20me3 | H3K27me3 | ||||
| Human MAR 1-68 | |||||||||||
| Human MAR X-29 | |||||||||||
| Murine MAR S4 | |||||||||||
| Chicken Lysozyme MAR | |||||||||||
| HS4 Insulator | |||||||||||
| 1 kb UCOE Element | |||||||||||
| Star Element 40 | |||||||||||
aThe boundary or barrier activity is shown for each element, as determined by the number of eBFP2 expressing cells in polyclonal populations (Figure 2). Signs are based on the fold increase of expressing cells for a given element relative to cells transfected with the control construct with a spacer DNA of similar size. ++, + and – signs represent a >2 fold, a ≤2 fold but still significant, and a non-significant increase of eBFP2-positive cells, respectively.
bThe median cell fluorescence of expressing clones was used to determine transcriptional activation (Figure 3A). Significant fold increases of >3 (++) or >2 (+) fold are shown.
cThe frequency of reactivation events, based on the number of silent clones which display expressing cells after 2 weeks of culture (Figure 3D) are shown as ++ (>20%), + (>10%) or – (≤10%) for each epigenetic element.
dEnrichment (+) and depletion (−) of the different histone marks on either the telomeric-proximal DsRed (grey signs) or the telomeric-distal eBFP2 (black signs) based on ChIP data (Figure 4). Double signs correspond to a fold increase >2-fold (++) or <0.5-fold (−−) relative to the spacer control. A tilde sign (∼) indicates that no significant change was observed relative to the spacer control.